Terms: = Sarcomas AND KIF5B, ENSG00000170759, 3799, P33176, UKHC, KNS1, KNS, KINH
5 results:
1. Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement.
Gao QY; Xiao FM; Lin XC; Chen YQ; Li YF; Lu C; Su JW; Tan QQ; Zhang CY; Yang J; Wu YL; Chen HJ; Yang JJ
Cancer Treat Res Commun; 2023; 35():100707. PubMed ID: 37121144
[TBL] [Abstract] [Full Text] [Related]
2. Recurrent RET fusions in fibrosarcoma-like neoplasms in adult viscera: expanding the clinicopathological and genetic spectrum.
Zhao M; Yin X; He H; Xia Q; Ru G
Histopathology; 2023 Mar; 82(4):633-645. PubMed ID: 36443894
[TBL] [Abstract] [Full Text] [Related]
3. ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights.
Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
[TBL] [Abstract] [Full Text] [Related]
4. ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report.
Tian Y; Li J; Liu B; Xie H; Zheng M; Yao W
Ann Palliat Med; 2021 Sep; 10(9):10095-10101. PubMed ID: 34628929
[TBL] [Abstract] [Full Text] [Related]
5. Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response.
Axenovich SA; Kazarov AR; Boiko AD; Armin G; Roninson IB; Gudkov AV
Cancer Res; 1998 Aug; 58(15):3423-8. PubMed ID: 9699675
[TBL] [Abstract] [Full Text] [Related]
